JCI - Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of
HIV-1 and tuberculosis coinfection Go to JCI Insight About Editors Consulting Editors For authors …

Few studies from Africa have described the clinical impact of co-infections on SARS-CoV-2
infection. Here, we investigate the presentation and outcome of SARS-CoV-2 infection in an …

We read an interesting study in your journal. A retrospective study by Liu et al. was
conducted to investigate the associated between lymphocyte subset counts and severe …

Objectives The aim was to investigate if there is a synergy in HIV and COVID-19 in their
influence upon human immunity; if there is an exacerbation of HIV patients' immune status …

COVID-19 is a distinctive infection characterized by elevated inter-human transmission and
presenting from absence of symptoms to severe cytokine storm that can lead to dismal …

Objectives The interaction of COVID-19 and tuberculosis (TB) are still poor characterized.
Here we evaluated the immune response specific for Micobacterium tuberculosis (Mtb) and …

Disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ranges from mild illness to severe respiratory disease and death. In this study, we …

The novel coronavirus disease 19 (COVID-19) is an acute infectious respiratory disorder that
emerged from Wuhan, China in the late 2019. 1, 2 Due to its rapid distribution, the disease …

The emergence of SARS-CoV-2 variants with evidence of antibody escape highlight the
importance of addressing whether the total CD4+ and CD8+ T cell recognition is also …

Introduction Patients with chronic underlying diseases are more susceptible to coronavirus
disease 2019 (COVID‐19) complications. Recent studies showed people living with HIV …